Fisetin Tetramethyl Ether

Fisetin Tetramethyl Ether

SCHEMBL7116147

COc1ccc2c(=O)c(OC)c(-c3ccc(OC)c(OC)c3)oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 10/20 1.00
ABCB1 P08183 7/20 0.81
KDM4E B2RXH2 3/20 0.70
MEN1 O00255 3/20 0.70
ALDH1A1 P00352 3/20 0.70
CYP3A4 P08684 3/20 0.70
KMT2A Q03164 3/20 0.70
MAPT P10636 3/20 0.70
HPGD P15428 2/20 0.70
HSD17B10 Q99714 2/20 0.70
THRB P10828 1/20 0.70
ABCC1 P33527 4/20 0.70
MAPK1 P28482 1/20 0.70
TDP1 Q9NUW8 1/20 0.70
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
NPC1 O15118 1/20 0.60
RAB9A P51151 1/20 0.60
TUBB4A P04350 1/20 0.59
TUBB P07437 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2417046 0.90 ABCB1 (1.00) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL7119192 0.90 ABCG2 (0.81) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL20339678 0.87 ABCG2 (0.78) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL24614952 0.86 ABCG2 (1.00) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL10335360 0.86 ABCB1 (0.80) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL1627832 0.84 KDM4E (0.82) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL3958745 0.84 ABCG2 (0.72) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL28431125 0.83 ABCG2 (0.73) ABCG2ABCB1KDM4EMEN1ALDH1A1
SCHEMBL31723172 0.83 ABCG2 (0.73) ABCG2ABCB1KDM4EMEN1ALDH1A1
3,7-Dimethoxyflavone SCHEMBL4278796 0.83 ALDH1A1 (1.00) ABCG2ABCB1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed
EP-0290442-A4 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. CHEMEX PHARMACEUTICALS INC (US) 1990-07-03 EP claimed
EP-0290442-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-11-17 EP claimed
WO-1988003805-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-06-02 WO claimed
CN-111825364-B Preparation method of environment-friendly naphthalene water reducer 安徽鑫固环保股份有限公司 2022-06-14 CN disclosed
CN-111825364-A Preparation method of environment-friendly naphthalene water reducer 安徽鑫固环保股份有限公司 2020-10-27 CN disclosed
CN-111807738-A Additive for geopolymer 安徽鑫固环保股份有限公司 2020-10-23 CN disclosed
CN-111808641-A Novel water-coal-slurry dispersant and preparation method thereof 萧县沃德化工科技有限公司 2020-10-23 CN disclosed
CN-111808651-A 2-naphthol distillation residue modified coal water slurry dispersing agent and preparation method thereof 萧县沃德化工科技有限公司 2020-10-23 CN disclosed
CN-111792867-A Naphthalene water reducer containing distillation residues 萧县沃德化工科技有限公司 2020-10-20 CN disclosed
CN-111792868-A Environment-friendly naphthalene-based high-efficiency water reducing agent and preparation method thereof 萧县沃德化工科技有限公司 2020-10-20 CN disclosed
US-20170071902-A1 NOX INHIBITOR AND NFkB INHIBITOR CONTAINING METHOXYFLAVONE SUNTORY HOLDINGS LIMITED (JP) 2017-03-16 US disclosed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO disclosed
EP-0290442-A4 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. CHEMEX PHARMACEUTICALS INC (US) 1990-07-03 EP disclosed
EP-0290442-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-11-17 EP disclosed
WO-1988003805-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170071902-A1 NOX INHIBITOR AND NFkB INHIBITOR CONTAINING METHOXYFLAVONE NOX1, NFKBIA, NOX5 ABCG2 4110/4885ABCB1 1908/4885KDM4E 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.